Cargando…
Paradoxical Suppression of Atherosclerosis in the Absence of microRNA-146a
RATIONALE: Inflammation is a key contributor to atherosclerosis. MicroRNA-146a (miR-146a) has been identified as a critical brake on proinflammatory nuclear factor κ light chain enhancer of activated B cells signaling in several cell types, including endothelial cells and bone marrow (BM)–derived ce...
Autores principales: | Cheng, Henry S., Besla, Rickvinder, Li, Angela, Chen, Zhiqi, Shikatani, Eric A., Nazari-Jahantigh, Maliheh, Hammoutène, Adel, Nguyen, My-Anh, Geoffrion, Michele, Cai, Lei, Khyzha, Nadiya, Li, Tong, MacParland, Sonya A., Husain, Mansoor, Cybulsky, Myron I., Boulanger, Chantal M., Temel, Ryan E., Schober, Andreas, Rayner, Katey J., Robbins, Clinton S., Fish, Jason E. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Lippincott Williams & Wilkins
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5542783/ https://www.ncbi.nlm.nih.gov/pubmed/28637783 http://dx.doi.org/10.1161/CIRCRESAHA.116.310529 |
Ejemplares similares
-
MicroRNA-146 represses endothelial activation by inhibiting pro-inflammatory pathways
por: Cheng, Henry S, et al.
Publicado: (2013) -
Immunological Determinants of Liver Transplant Outcomes Uncovered by the Rat Model
por: Wang, Xinle, et al.
Publicado: (2021) -
Noncoding RNAs regulate NF-κB signaling to modulate blood vessel inflammation
por: Cheng, Henry S., et al.
Publicado: (2014) -
Restoration of HCV-Specific Immune Responses with Antiviral Therapy: A Case for DAA Treatment in Acute HCV Infection
por: Casey, Julia L., et al.
Publicado: (2019) -
Profiling RNA at chromatin targets in situ by antibody-targeted tagmentation
por: Khyzha, Nadiya, et al.
Publicado: (2022)